Literature DB >> 17592545

Prostate-Cancer Risk Stratification via Early PSA Testing.

Danil V Makarov1, Alan W Partin.   

Abstract

Entities:  

Year:  2007        PMID： 17592545      PMCID： PMC1892624     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  8 in total

1.  American Cancer Society guidelines for the early detection of cancer.

Authors:  Robert A Smith; Vilma Cokkinides; Andrew C von Eschenbach; Bernard Levin; Carmel Cohen; Carolyn D Runowicz; Stephen Sener; Debbie Saslow; Harmon J Eyre
Journal:  CA Cancer J Clin       Date:  2002 Jan-Feb       Impact factor: 508.702

2.  Prostate-specific antigen (PSA) best practice policy. American Urological Association (AUA).

Authors: 
Journal:  Oncology (Williston Park)       Date:  2000-02       Impact factor: 2.990

3.  Low levels of prostate-specific antigen predict long-term risk of prostate cancer: results from the Baltimore Longitudinal Study of Aging.

Authors:  J Fang; E J Metter; P Landis; D W Chan; C H Morrell; H B Carter
Journal:  Urology       Date:  2001-09       Impact factor: 2.649

4.  Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Authors:  P C Prorok; G L Andriole; R S Bresalier; S S Buys; D Chia; E D Crawford; R Fogel; E P Gelmann; F Gilbert; M A Hasson; R B Hayes; C C Johnson; J S Mandel; A Oberman; B O'Brien; M M Oken; S Rafla; D Reding; W Rutt; J L Weissfeld; L Yokochi; J K Gohagan
Journal:  Control Clin Trials       Date:  2000-12

5.  Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.

Authors:  Hans Lilja; David Ulmert; Thomas Björk; Charlotte Becker; Angel M Serio; Jan-Ake Nilsson; Per-Anders Abrahamsson; Andrew J Vickers; Göran Berglund
Journal:  J Clin Oncol       Date:  2007-02-01       Impact factor: 44.544

6.  Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability.

Authors:  H Ballentine Carter; Luigi Ferrucci; Anna Kettermann; Patricia Landis; E James Wright; Jonathan I Epstein; Bruce J Trock; E Jeffrey Metter
Journal:  J Natl Cancer Inst       Date:  2006-11-01       Impact factor: 13.506

7.  Relationship between initial prostate specific antigen level and subsequent prostate cancer detection in a longitudinal screening study.

Authors:  Jo Ann V Antenor; Misop Han; Kimberly A Roehl; Robert B Nadler; William J Catalona
Journal:  J Urol       Date:  2004-07       Impact factor: 7.450

8.  European randomized study of screening for prostate cancer. Progress report of Antwerp and Rotterdam pilot studies.

Authors:  F H Schröder; L J Denis; W Kirkels; H J de Koning; B Standaert
Journal:  Cancer       Date:  1995-07-01       Impact factor: 6.860
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.